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Abstract
Background: Use of Botulinum toxin-A (BoNT-A) for treatment of upper limb spasticity in children with cerebral palsy 
has become routine clinical practice in many paediatric treatment centres worldwide. There is now high-level evidence 
that upper limb BoNT-A injection, in combination with occupational therapy, improves outcomes in children with 
cerebral palsy at both the body function/structure and activity level domains of the International Classification of 
Functioning, Disability and Health. Investigation is now required to establish what amount and specific type of 
occupational therapy will further enhance functional outcomes and prolong the beneficial effects of BoNT-A.
Methods/Design: A randomised, controlled, evaluator blinded, prospective parallel-group trial. Eligible participants 
were children aged 18 months to 6 years, diagnosed with spastic hemiplegic cerebral palsy and who were able to 
demonstrate selective motor control of the affected upper limb. Both groups received upper limb injections of BoNT-A. 
Children were randomised to either the modified constraint-induced movement therapy group (experimental) or 
bimanual occupational therapy group (control). Outcome assessments were undertaken at pre-injection and 1, 3 and 6 
months following injection of BoNT-A. The primary outcome measure was the Assisting Hand Assessment. Secondary 
outcomes included: the Quality of Upper Extremity Skills Test; Pediatric Evaluation of Disability Inventory; Canadian 
Occupational Performance Measure; Goal Attainment Scaling; Pediatric Motor Activity Log; modified Ashworth Scale 
and; the modified Tardieu Scale.
Discussion: The aim of this paper is to describe the methodology of a randomised controlled trial comparing the 
effects of modified constraint-induced movement therapy (a uni-manual therapy) versus bimanual occupational 
therapy (a bimanual therapy) on improving bimanual upper limb performance of children with hemiplegic cerebral 
palsy following upper limb injection of BoNT-A. The paper outlines the background to the study, the study hypotheses, 
outcome measures and trial methodology. It also provides a comprehensive description of the interventions provided.
Trial Registration: ACTRN12605000002684
Background
Cerebral palsy is "a group of permanent disorders of the
development of movement and posture causing activity
limitation(s) that are attributed to non-progressive dis-
turbances that occurred in the developing fetal or infant
brain" [[1], p. 9]. Secondary to the brain disturbance, chil-
dren with cerebral palsy often experience neurological
symptoms including dystonia, ataxia, athetosis and par-
ticularly spasticity [2]. Spasticity occurs as a result of a
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loss of upper motor neuron inhibition on the lower motor
neurons which results in increased or impaired motor
unit firing and altered muscle tone [2]. Muscle spasticity
is characterised by a velocity-dependent increase in tonic
stretch reflexes (muscle tone) with exaggerated tendon
jerks (phasic stretch reflex) resulting from hyperexcitabil-
ity of the stretch reflex [3]. Adding to these neurological
symptoms, skeletal muscle morphology in children with
cerebral palsy is also altered due to abnormally long mus-
cle sarcomere lengths and muscle tissue containing a
hypertrophic extracellular matrix of poor quality [2,4].
This results in muscle stiffness affecting posture and
movement and can be described as hypertonia or
increased muscle tone [3].
Hemiplegic cerebral palsy, characterised by a clinical
pattern of unilateral motor impairment, accounts for
35.1% of all cerebral palsy types in Victoria, Australia [5],
15.3% in Ontario, Canada, 40% in Sweden [6] and 31.2%
in North England, United Kingdom [7]. Along with mus-
cle spasticity and hypertonia, children with hemiplegic
cerebral palsy experience a loss of upper motor neurone
excitation that is typically associated with poor selective
motor control and weakness, and in some instances, sen-
sory deficits. These additional impairments significantly
impact on a child's ability to perform daily tasks [8-11].
The spastic motor type of cerebral palsy is the most
c o m m o n ,  c o m p r i s i n g  a b o u t  8 0 %  o f  a l l  r e p o r t e d  c a s e s
[12]. Although the mechanism is unknown, spastic mus-
cle often shortens to create muscle contractures, which
often leads to fixed deformity and further functional
complications [13]. Therefore, management of the upper
limb in children with cerebral palsy usually involves a
variety of interventions targeting the musculoskeletal sys-
tem. These may include splinting and casting, passive
stretching, the facilitation of posture and movement (e.g.
occupational therapy and physiotherapy) or systemic
spasticity-reducing medication and surgery [14]. Botuli-
num toxin-A (BoNT-A) is now commonly used as an
adjunct to these interventions.
Botulinum toxin-A in the treatment of the upper limb in 
children with cerebral palsy
BoNT-A is a powerful neuromuscular paralysing agent
that is produced by the anaerobic bacterium clostridium
botulinum [15]. BoNT-A acts at the neuromuscular junc-
tion by inhibiting the release of the neurotransmitter ace-
tylcholine. Injection of BoNT-A into selected muscles
produces dose-dependent chemical denervation resulting
in reduced muscle activity. The denervation is temporary
as sprouting of new nerve terminals from the treated
nerves leads to re-innervation. The function of the origi-
nal terminal is eventually restored leading to the recovery
of the affected muscles [16]. The period of clinically use-
ful relaxation appears to be 12-16 weeks [12]. The aim of
BoNT-A in the treatment of the upper limb in children
with cerebral palsy is to produce selective reduction in
muscle spasticity using the smallest possible dose. The
reduction in spasticity is intended to provide an opportu-
nity to optimise the effects of motor training by reducing
the negative interference of spasticity. It can also serve to
improve tolerance and compliment the effects of splint-
ing and casting potentially delaying the need for soft tis-
sue surgery [9].
Use of BoNT-A for the treatment of upper limb spastic-
ity in children with cerebral palsy has become routine
clinical practice in many paediatric treatment centres
worldwide. In Australia, injection of BoNT-A (Botox(r)
only) is now an approved and government funded treat-
ment for moderate to severe spasticity of the upper limbs
children with cerebral palsy, 2 to 17 years of age inclusive
[17]. A recent Cochrane review, including ten ran-
domised controlled trials predominantly of high quality,
provided high-level evidence that BoNT-A in the upper
limb, in combination with occupational therapy,
improved outcomes at both the body function/structure
and activity level domains of the International Classifica-
tion of Functioning, Disability and Health (ICF) [18]
when compared to occupational therapy alone, BoNT-A
alone or no treatment [19]. The review authors concluded
that injection of BoNT-A in the upper limb in children
with cerebral palsy should always be accompanied by
planned post-injection therapeutic intervention. This
conclusion is consistent with a recently developed inter-
national collaboration documenting upper limb BoNT-A
evidence-based guidelines for intervention and follow-up
for children with cerebral palsy [20].
Intramuscular injection of BoNT-A results in relax-
ation of the affected muscle providing a window of
opportunity for maximising therapy outcomes. For chil-
dren with hemiplegia however, injection of BoNT-A
alone does not improve the ability of the child to use the
affected limb and clinical experience suggests attempts to
use the limb immediately following injection often
remain effortful, inefficient and result in clumsy move-
ment. Persistent verbal and physical encouragement by
therapists and parents may frequently lead to further
frustration and negative or defiant behavior. Therapy
must, therefore, create the opportunity, motivation, expe-
rience and environment in which a child can learn how to
use their affected limb to maximize the effectiveness of
the BoNT-A.
A recent systematic review of all upper limb interven-
tions in children with cerebral palsy found that occupa-
tional therapy in combination with BoNT-A produced
the largest treatment effect of all upper limb interven-
tions on activity level outcomes [21]. Despite high-level
evidence supporting occupational therapy post-injec-
tion, no clinical trial has specifically investigated the opti-Hoare et al. BMC Neurology 2010, 10:58
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mal type and amount of therapy following BoNT-A.
Approaches undertaken in recent trials however, all point
to the effectiveness of bursts of therapy focused on spe-
cific skill acquisition or goal achievement [22-26]. Further
investigation is required to establish what intensity and/
or specific type of therapy will enhance functional out-
comes and prolong the beneficial effects of BoNT-A [14].
Movement-based therapies in the upper limb
For occupational therapists, bimanual occupational ther-
apy training (BOT) in children with hemiplegia is a com-
monly applied intervention. Theories of practice have
previously been described in the literature [27-29],
although clinical service delivery is eclectic and poten-
tially covers a range of interventions. An essential ele-
ment of the bimanual approach to upper limb training
includes the repetitive practice of motivating, meaningful
and purposeful bimanual activities (i.e. occupations).
This has been well supported by recent advances in the
areas of neuroscience, basic mechanisms of hand func-
tion and more specifically, motor control and motor
learning theories [30]. Although this approach is com-
monly used and has strong theoretical foundations, it has
not been systematically defined and empirically investi-
gated.
In 2007, Gordon and colleagues comprehensively
described and evaluated a bimanual approach to upper
limb training in children with hemiplegic cerebral palsy
called Hand Arm Bimanual Intensive Training (HABIT)
[31]. Despite similarities with BOT, specific differences
exist between the therapies. HABIT includes: high inten-
sity of treatment (6 hours per day for 2 weeks); the use of
behavioural shaping theory [32]; and relies solely on envi-
ronmental adaptation for grading of activities, rather
than physical assistance or handling of the child (Andrew
Gordon, personal communication). Children participat-
ing in HABIT demonstrated improved bimanual upper
limb function compared with a group receiving custom-
ary care [31]. However, the promising evidence provided
by this small trial of moderate methodological quality
suggests that further investigation of bimanual interven-
tion in children with hemiplegia is both justified and war-
ranted [28].
Constraint-induced movement therapy (CIMT) has
been adopted as a method of teaching a child to use his/
her affected upper limb through use of a restraint on the
non-affected limb and massed practice of movements of
the affected limb [33]. It has been proposed as an effec-
tive way of improving outcomes following upper limb
BoNT-A injection, particularly as it removes the need for
persistent prompting [34]. It may, on the other hand, lead
t o  t h e  o p p o s i t e  e f f e c t  i f  a  c h i l d  d e m o n s t r a t e s  a d v e r s e
behavioral responses to the restraint [33].
Developmental disregard is a term used to describe a
child with hemiplegia who may disregard, or learn not to
use, the affected limb during the development of motor
function [35]. Children with even mild impairment in the
affected limb learn effective strategies to manage daily
tasks (e.g. play) with one hand, discovering that perfor-
mance is more efficient using only the non-affected hand
[10]. Constraint-Induced Movement Therapy (CIMT),
aims to reverse the behavioral suppression of movement
in the affected upper limb by constraining use of the non-
affected limb and providing massed practice of activities
with the affected limb [36]. Studies in adults following
stroke have provided evidence of adaptation in the brain
involving the motor cortical areas controlling movement
of the more affected limb following CIMT [37-39]. Since
the potential for central nervous system plasticity in
young children is increased relative to adults [40-42], it is
postulated that this approach might prove to be especially
effective in children [43].
CIMT is a multi-faceted intervention and studies
describing its use in children with cerebral palsy present
wide variation in its application in relation to: method of
restraint; length of restraint (per day, number of weeks);
type and duration of therapy; intervention environment
(that is home, school, or clinic) and intervention provider
(therapist, parent, or teacher). Children included in stud-
ies have also varied in age, diagnosis, severity of motor
and sensory impairment, cognitive abilities and behavior.
Despite the emerging popularity of CIMT in children
with hemiplegic cerebral palsy, a Cochrane review [44]
identified a significant treatment effect in only a single
trial which adopted a less intensive modified form of
CIMT [8]. The modified CIMT (mCIMT) involved the
application of a restraint on the unaffected upper limb
and less than three hours per day of therapy provided to
the affected limb [44]. While a positive trend was found
favoring CIMT [35] and Forced Use [45], no significant
treatment effect was demonstrated for these interven-
tions when compared with traditional services.
Studies published to date have provided limited evi-
dence of factors that may impact on the effectiveness of
CIMT. Response to CIMT does not appear to be age-
dependent and children with more impaired bimanual
hand function demonstrate greater improvement than
less impaired children [8]. Although not statistically sig-
nificant, trends have also been reported as favoring chil-
dren with cortical/subcortical lesions compared to those
with periventricular white matter lesions [8]. More
recently, Kuhnke et al., [46] reported that adolescents and
young adults with ipsilateral corticospinal projections
responded differently to CIMT intervention in compari-
son to those with contralateral projections. Although
these findings must be interpreted cautiously due to
methodological limitations [47], the study by Kuhnke etHoare et al. BMC Neurology 2010, 10:58
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al., [46] adds information about children's potential
responses to CIMT.
There is currently no published trial directly comparing
a BOT protocol with a CIMT protocol. However, in 2008
Gordon and colleagues [48] published data from a quasi-
randomised trial of 16 children with hemiplegic cerebral
palsy that compared a one-on-one uni-manual approach
to treatment (CIMT) versus a one-on-one bimanual
approach to treatment (HABIT) [48]. This small trial
reported similar changes for both groups on outcomes
including the Jebsen-Taylor Test of Hand Function,
Assisting Hand Assessment and accelerometry. The find-
ing, measured using the Assisting Hand Assessment,
indicated immediate post-treatment improvements in
upper limb bimanual performance using either a uni-
manual or bimanual approach to training. However,
retention of gains was not examined following either
intervention.
Methods/Design
The aim of this current paper is to describe the method-
ology of a randomised controlled trial comparing the
effects of modified constraint-induced movement ther-
apy (a uni-manual therapy) versus conventional bimanual
occupational therapy on improving bimanual upper limb
performance of children with hemiplegic cerebral palsy
following upper limb injection of BoNT-A. Bimanual
upper limb performance, assessed using the Assisting
Hand Assessment, was selected as the primary measure
as the central aim of all upper limb motor-based inter-
ventions in children with hemiplegia is to improve a
child's actual use of their affected upper limb in a range of
daily tasks, including those requiring bimanual perfor-
mance; rather than what they can do in a clinical setting
or how normal their movement appears. This RCT builds
on the existing evidence supporting the use of BoNT-A in
the upper limb of children with cerebral palsy. It aims to
identify the most effective intervention following injec-
tion of BoNT-A. A further aim is to explore the individual
characteristics of children that impact on response to
treatment. Finally, it will also provide additional evidence
regarding dose response to treatment, specificity of train-
ing effects, and the retention of treatment effects.
Primary objective
To compare the effects of modified CIMT versus biman-
ual occupational therapy (BOT) in improving the biman-
ual performance of children with hemiplegic cerebral
palsy following upper limb BoNT-A injection.
Hypothesis 1
Modified CIMT is more effective than conventional BOT
in improving the bimanual performance of children with
hemiplegic cerebral palsy following upper limb BoNT-A
injection.
Hypothesis 2
Relative to baseline performance on the Assisting Hand
Assessment, modified CIMT results in greater retention
of gains in bimanual performance compared with BOT.
Secondary objectives
A. To compare the effect of modified CIMT versus
bimanual occupational therapy (BOT) on secondary out-
comes relating to: the performance of activities of daily
living; the quality of upper limb movement; occupational
performance; individual goal achievement; and frequency
of use of the affected upper limb of children with hemi-
plegic cerebral palsy following upper limb BoNT-A injec-
tion.
Hypothesis 3
Modified CIMT is more effective than conventional BOT
in improving performance of activities of daily living,
quality of upper limb movement, occupational perfor-
mance, individual goal achievement and frequency of use
of the affected upper limb in children with hemiplegic
cerebral palsy following upper limb BoNT-A injection.
B. To evaluate the clinical significance of change identi-
fied on the primary outcome, the Assisting Hand Assess-
ment.
Hypothesis 4
That changes on the Assisting Hand Assessment associ-
ated with intervention are of a clinically significant mag-
nitude. Clinical significance was defined as a change
score of more than 5 raw score points (2.6 logits) on the
AHA (Lena Krumlinde-Sundholm, personal communica-
tion).
C. To evaluate the impact of age and actual treatment
dosage on the primary outcome, the Assisting Hand
Assessment.
Hypothesis 5
Younger children (irrespective of treatment type) will
show greater improvement in bimanual performance fol-
lowing uni-manual or bimanual therapy and upper limb
BoNT-A injection.
Hypothesis 6
Children who undertake treatment of greatest intensity
(irrespective of treatment type) will show greater
improvement in bimanual performance.
Study design
Randomised, controlled, evaluator-blinded, prospective
parallel-group trial based on Consolidated Standards of
Reporting Trials (CONSORT) Statement for Randomised
Trials of Non-Pharmacologic Treatment [49].
Participants
Children were eligible to participate if they met the fol-
lowing criteria:Hoare et al. BMC Neurology 2010, 10:58
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Inclusion Criteria
• Diagnosis of congenital spastic hemiplegic cerebral
palsy as diagnosed and reported in the medical history by
a medical specialist (i.e. neurologist, paediatrician).
• Aged 18 months to 6 years at time of recruitment.
• Active movement of the shoulder, elbow, wrist, digits
and thumb of the affected upper limb, such that the:
• child is able to reach forward to an elevated position 
in front with mid range shoulder flexion.
• child is able to grasp a 2.5 cm cube from a table top 
and release it in a large container (20 cm × 14 cm).
• Able to attend to tasks and follow simple one stage
commands.
• child is able to actively perform reach and grasp/
release activities with verbal prompting.
• Moderate levels of muscle tone (i.e. 1-2, modified 
Ashworth scale) and spasticity (i.e. 1-2, Tardieu scale) 
and no fixed contracture in target group of muscles to 
be injected with BoNT-A.
• Parents able to commit to an intensive therapy pro-
gram and agree to cease all other upper limb thera-
peutic interventions for the 6-month period of the 
trial.
• Assessed as appropriate for upper limb BoNT-A at 
neuromuscular clinic by rehabilitation specialist (BR).
Exclusion Criteria
Children who otherwise met the inclusion criteria were
excluded if they had:
• Congenital quadriplegic or diplegic cerebral palsy.
• Previous BoNT-A injections in the upper limb in the
past 12 months.
• Prior upper limb surgery (i.e. tendon transfer/tendon
lengthening).
• Existing treatments that are not compatible with
those those included in the study treatment package.
There were no criteria relating to exclusion of children
with mother tongue other than English, presence of co-
morbidity or socio-economic status.
Recruitment
Potential participants were identified from the Physical
Rehabilitation Clinic of a major paediatric metropolitan
hospital. In addition, postal and email advertising were
sent to local medical practitioners and paediatric therapy
networks in metropolitan Melbourne. Potential partici-
pants were screened by the chief investigator (BJH) to
determine eligibility. Children eligible for inclusion were
then assessed by an experienced rehabilitation specialist
for suitability for upper limb BoNT-A injection (HBR).
Suitable children were then invited to participate in the
RCT and informed consent obtained for the participation
of the child and the child's parent prior to enrolment in
the RCT.
Procedure
The RCT was approved by the Ethics Committee of both
Southern Health and La Trobe University. The trial is
registered with the Australian New Zealand Clinical Tri-
als Registry (ACTRN12605000002684) [50]. Data was
collected from August 2003 until May 2009.
Reliability training for assessment and scoring of outcome 
measures
Prior to commencement of the RCT, two highly experi-
enced paediatric therapists (one occupational therapist,
one physiotherapist) were trained in the administration
of all outcome measures. A manual was developed for
both therapists to ensure consistency in measurement
over the recruitment period. The same occupational
therapist collected data for the Assisting Hand Assess-
ment, Quality of Upper Extremity Skills Test, Pediatric
Evaluation of Disability Inventory, Pediatric Motor Activ-
ity Log, Canadian Occupational Performance Measure
and Goal Attainment Scaling for the entire recruitment
period. Two physiotherapists collected data for the modi-
fied Ashworth and modified Tardieu Scales. Scoring of
the Assisting Hand Assessment was undertaken by the
assessment developers. The Quality of Upper Extremity
Skills Test was scored by a highly experienced paediatric
occupational therapist who had significant experience in
the assessment and treatment of children following upper
limb BoNT-A injections.
Randomisation
Sequence generation
Children were block randomised into pairs matched by
age (± 6 months) using a computer generated set of ran-
dom numbers.
Allocation Concealment
A set of random numbers was used to create an allocation
sequence which was contained in individual opaque
envelopes for use by the chief investigator (BJH). As chil-
dren were recruited, the next envelope in the sequence
was opened and the child assigned to the stated group.
Implementation
All randomisation, sequence generation, and preparation
of group allocation materials were performed by a third
party (the Monash Institute of Health Services Research)
who had no direct contact with the clinical aspects of the
trial. The master list of random numbers was located in
l o c k e d  c a b i n e t s  a t  t h e  I n s t i t u t e  a n d  o n l y  a c c e s s i b l e  a t
completion of the RCT for analysis.
Blinding
Due to the overt nature of the interventions, children,
their parents and the treating therapist were not blinded
to group assignment, however, children and parents wereHoare et al. BMC Neurology 2010, 10:58
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blind to the RCT hypotheses. Outcome measures were
administered by a therapist blind to group assignment
and scored by different assessors who were blind to group
allocation. The Assisting Hand Assessment and Quality
of Upper Extremity Skills Test was videotaped, ran-
domised and scored by assessors blind to group alloca-
tion and order of assessment.
Sample Size
Sample size estimates were based on projected treatment
effect on the primary outcome measure, the Assisting
Hand Assessment. In 2005, the authors suggested that a
change of more than 5 raw score points may represent a
clinically meaningful difference on the Assisting Hand
Assessment (Lena Krumlinde-Sundholm, personal com-
munication). This was the equivalent to a change in 2.6
logits. Calculation for fractions of logits undertaken by a
statistician indicated that in order to detect a change of
2.6 logits a minimum sample size of 17 per group was
required. As the RCT design involves a two-group design,
a total sample size of 34 was required to provide 80%
p o w e r  t o  d e t e c t  c l i n i c a l l y  m e a n i n g f u l  c h a n g e  b e t w e e n
groups. Therefore, the study aimed to recruit 40 children
to allow for a 10-12% drop-out rate.
Outcome measures
Outcomes measures were completed on four occasions:
baseline (1 to 2 weeks prior to injection), and at 1, 3 and 6
months after injection. Outcomes included measures
from across the International Classification of Function-
i n g ,  D i s a b i l i t y  a n d  H e a l t h  ( I C F )  [ 1 8 ]  s p e c t r u m  a n d
involved a combination of investigator observed and par-
ent report measures (See Table 1). This enabled analysis
of the impact of intervention across the body function
and activity domains.
The effects of upper limb BoNT-A injection in both
groups were monitored using measures of muscle spas-
ticity and muscle tone including the Modified Ashworth
Scale (MAS) and Modified Tardieu Scale (MTS).
Primary Outcome
The primary outcome measure was the Assisting Hand
Assessment (AHA) [51]. The administration of the AHA
(Small Kids English version 4.4) was videotaped. The
AHA is a standardized, criterion-referenced test for use
with children aged 18 months to 12 years, who have a
unilateral upper limb impairment [51]. It aims to measure
how effectively a child uses their affected hand in biman-
ual play activities using 22 items. Unlike most other
upper limb assessments for children with cerebral palsy,
the AHA attempts to capture a child's typical perfor-
mance when performing tasks rather than their best
effort or "capacity" [51]. Change on the AHA is therefore
more likely to reflect change in the child's upper limb use
across multiple environments.
The AHA is conducted by video observation of the
child involved in a 10-15 minute play session using the
AHA test kit with specific toys. The twenty-two items
defining different actions are then scored on a 4-point
scale rating the quality of the performance. Four being
effective, 3 somewhat effective, 2 ineffective and 1 indi-
cating the child does not perform the action. The sum of
raw scores (sum score) varies between 22 (low ability) to
88 points (high ability). Raw scores are converted to
scaled scores ranging from 0 to 100. Using a computer
generated logarithmic transformation, ordinal data are
then converted to equal intervals in the unit logits [51].
The range of the AHA scale is -10.18 to +8.70 logits.
Logit scores will be used in the analysis of data for this
RCT.
The psychometric properties of the AHA have been
described in several studies [51-54]. Using Rasch mea-
surement analysis, validity and aspects of reliability were
evaluated, with excellent results. There is strong evidence
that AHA items measure a uni-dimensional construct
with 95% of items fitting Rasch assumptions. Person
r e s p o n s e  v a l i d i t y  d e m o n s t r a t e d  t h a t  9 7 %  o f  p e r s o n ' s
responses fitted the model. A person separation index of
6.16 demonstrated a very good ability to distinguish chil-
dren of different ability levels [51,52]. A standard error
mean of 0.28 (range 0.26-0.32) revealed the precision and
reliability of the item measures [51]. More recently, reli-
ability of the Small Kids AHA was found to be excellent
with Intraclass Coefficients (ICC's) of 0.97 (20 raters) to
0.98 (2 raters) for interrater and for the intrarater 0.99
[53]. The same version also demonstrated excellent test-
retest reliability (ICC 0.99). The Smallest Detectable Dif-
Table 1: Outcomes classified according to International Classification of Functioning, Disability and Health (ICF)
Body Function Activity
Capacity Performance
modified Tardieu Scale (MTS), modified 
Ashworth Scale (MAS), Quality of Upper 
Extremity Skills Test (QUEST; dissociated 
movement subscale)
Quality of Upper Extremity Skills Test 
(grasps subscale)
Assisting Hand Assessment (AHA), Canadian 
Occupational Performance Measure (COPM), 
Goal Attainment Scaling (GAS), Pediatric 
Evaluation of Disability Inventory (PEDI), 
Pediatric Motor Activity Log (PMAL)Hoare et al. BMC Neurology 2010, 10:58
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ference (SDD) over time indicated that a change in AHA
scores from one test session to the next must be 3.89 sum
scores (0.97 logits) or more to be considered a true
change with 95% probability [54]. The AHA was initially
designed for evaluation within a trial of CIMT [8] where
it demonstrated responsiveness to change. Since then,
studies evaluating HABIT [31,48] have also shown some
change in the treatment group compared to the control
group, providing evidence that the AHA was also respon-
sive to change following bimanual intervention.
Monitoring responses to Botulinum toxin-A injection
The Modified Ashworth Scale (MAS) is a 6-point, crite-
rion referenced ordinal scale deigned to measure the
resistance that is encountered when a limb is moved pas-
sively [55]. Scores range from 0 (no increase in muscle
tone) to 4 (rigid). Movements assessed included: shoulder
abduction and flexion; elbow extension and flexion; fore-
arm supination and pronation; wrist extension and flex-
ion; ulnar and radial deviation and thumb abduction.
The MAS has often been described in the literature as a
measure of spasticity [55,56], however since muscle resis-
tance in children with cerebral palsy is due to a combina-
tion of factors, only one of which is spasticity, the MAS is
considered to have poor validity for spasticity evaluation
[57]. Further, as there is no reference to the velocity of
limb movement during examination, a central criterion in
defining spasticity [3], the MAS is considered a measure
of muscle tone. Following a review of papers across a
broad range of diagnostic groups, Morris [58] estimated
intra-rater reliability to be between 0.55 to 0.83 and 0.45
to 0.84 for inter-rater reliability. These estimations have
been supported in recent studies in children with cerebral
palsy where inter-rater reliability has been described as
low [59,60]. To improve the reliability of using the MAS
in this RCT, two physiotherapists, independent to the
intervention component of the trial and experienced in
administration and scoring of the MAS performed all
assessments at a slow velocity. The MAS has demon-
strated change in children following upper limb injection
o f  B o N T - A  c o m b i n e d  w i t h  o c c u p a t i o n a l  t h e r a p y
[24,25,61].
The modified Tardieu scale (MTS) was adapted from
the original scale developed by Tardieu and colleagues
[62]. The MTS grades the quality of the reaction of the
muscle to passive stretch and measures the dynamic
component of muscle spasticity [63]. This measure of
spasticity is obtained when a joint is moved as fast as pos-
sible through its range of movement (V3 velocity) and the
angle of "catch" elicited is measured using a goniometer.
This is called R1. The difference between the angle of
"catch" (R1) and the full passive range of movement (R2)
reflects the potential range available in the joint if spastic-
ity is eliminated [9,63]. The quality of the muscle reaction
(resistance) is also rated when obtaining the R2 measure-
ment, from 0 (no resistance through the course of the
passive movement) to 5 (joint immovable).
In this RCT, administration of the MTS was jointly per-
formed by an occupational therapist and physiotherapist
both blinded to group assignment. Movements measured
included: shoulder abduction and flexion; elbow exten-
sion and flexion; forearm supination and pronation; wrist
extension and flexion; ulnar and radial deviation and
thumb abduction. The velocity used to determine the
angle of catch was V3 (as fast as possible), as recom-
mended by Morris [58]. The MTS scale has demonstrated
sensitivity to change when measuring spasticity following
BoNT-A injection in the upper limb [24] and lower limb
[63] in children with cerebral palsy. Despite this reported
sensitivity, the MTS has demonstrated poor reliability as
a measure of elbow flexor spasticity in children with cere-
bral palsy with large inter-sessional variation and diffi-
culty in applying standardised velocities [64]. The MTS
however, is still considered the only clinically valid mea-
sure of spasticity currently available [57,65]. To improve
reliability of the MTS in this RCT, the same blinded raters
(one occupational therapist, two physiotherapists) were
used for each assessment occasion for each child.
Secondary Outcomes
The secondary outcomes included measures of: quality of
upper limb movement (Quality of Upper Extremity Skills
Test (QUEST)); caregiver questionnaires relating to func-
tional status of the child (Pediatric Evaluation of Disabil-
ity Inventory (PEDI)) and perceived use of the affected
upper limb (Pediatric Motor Activity Log (PMAL)); indi-
vidual occupational performance (Canadian Occupa-
tional Performance Measure (COPM)); individual goal
attainment (Goal Attainment Scaling (GAS)); muscle
tone (the modified Ashworth Scale (MAS)); and spastic-
ity (the modified Tardieu Scale (MTS)).
The Quality of Upper Extremity Skills Test (QUEST) is
a descriptive, impairment-based measure designed to
evaluate movement patterns and hand function in chil-
dren with cerebral palsy [66]. The QUEST involves evalu-
ation of 36 items of upper extremity function in four
domains: dissociated movement, grasp, protective exten-
sion, and weight-bearing. For this RCT, both the affected
and unaffected upper limbs were tested. Each item is
scored as either a pass, fail or not-tested. A standardized
score is obtained for each domain using the formula
detailed in the manual [66] ranging from 0 (low ability) to
100 (high ability). A total score can be obtained by sum-
ming scores for each domain tested and dividing by the
total number of domains tested. In this RCT, despite data
for all domains being collected, only data from domains
targeted by the interventions and therefore likely to
change following mCIMT or BOT were analysed. TheseHoare et al. BMC Neurology 2010, 10:58
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include grasp and dissociated movement. This is consis-
tent with a more recent study evaluating the effects of
BoNT-A and occupational therapy [23].
The QUEST is a reliable and valid measure for evaluat-
ing the quality of movement in children with cerebral
palsy. Inter-observer ICC's range from 0.90 to 0.96 with
test-retest correlations of 0.95 [67]. Currently, there is no
evidence of the magnitude of change on individual
QUEST domains required to determine clinical signifi-
cance. The QUEST was originally designed to evaluate
Neuro-developmental Therapy (NDT) [68]. It has since
been widely adopted for use in trials evaluating BoNT-A
and occupational therapy [23,24,61,69] and CIMT [35].
The Pediatric Evaluation of Disability Inventory (PEDI)
[70] is a standardized assessment of how a child functions
with an impairment in the context of their daily life. It has
been standardized for children without impairment aged
6 months to 7.5 years and has established reliability and
validity to detect the presence, extent and area of a func-
tional delay in children with physical impairment or com-
bined physical and cognitive impairment [71]. The PEDI
is designed to measure a child's ability across 3 measure-
ment scales: functional skills, caregiver assistance, and
modifications used. Each scale is divided into 3 domains
of self-care, mobility and social function, each of which
can be administered separately.
Due to the nature of interventions provided in this trial
being targeted at upper limb function rather than mobil-
ity and social function, only the self-care domain of the
PEDI was administered. This is consistent with the use of
the PEDI in many other trials evaluating BoNT -A and
occupational therapy [23,25,26,72,73]. The 73 items in
the functional skills scale are rated on a 2-point scale with
0 indicating inability to perform a tasks and 1 indicating a
child is capable to perform the task. Eight items in the
caregiver assistance scale are rated on a 6-point scale
indicating the amount of assistance required to complete
a task (0 = total assistance, 1 = maximal assistance, 2 =
moderate assistance, 3 = minimal assistance, 4 = supervi-
sion and 5 = independent). Total raw scores are calcu-
lated by summing items from both the functional skills
and caregiver assistance scales. Higher scores for func-
tional skills level and caregiver assistance indicate better
performance and increased independence. Normative
standard scores and scaled scores are generated from the
raw scores. Scaled scores range from 0 to 100, with
increasing numbers representing increasing degrees of
functional performance. Scaled scores were used in the
data analysis for this trial.
PEDI scale construction was developed using Rasch
measurement model and analytic techniques to evaluate
construct validity and develop scaled scores. The PEDI
has established validity [71,74-76]. High intra-rater reli-
ability has been reported for self-care functional skills
(ICC's 0.97 - 0.99) and self-care caregiver assistance
(ICC's 0.94 - 0.99) [77,78]. Inter-rater reliability has been
reported for self-care functional skills when administered
as a parent interview [74,77]. In 2003, Iyer and colleagues
reported that change scores of about 11% on the total
scale appeared to represent clinically meaningful change
[79]. Although the PEDI has been reported to show
responsiveness to change over 6 months [80] more
recently reported trials evaluating upper limb injection of
BoNT-A in children with cerebral palsy, with or without
occupational therapy, did not demonstrate a significant
difference between groups [23,24,26,69,72]. As recom-
mended by Berg et al. [78] to improve reliability, a single
blinded assessor administered the PEDI in this RCT with
the same parent across all time periods.
The Canadian Occupational Performance Measure
(COPM) [81] is a client-centered measure designed to
detect change in a persons' perception of their occupa-
tional performance in self-care abilities, productivity (i.e.
for children school, pre-school activities) and leisure
activities. It has adequate validity, adequate test-retest
reliability (ICC of 0.63 for performance and 0.84 for satis-
faction) and responsiveness to change [81-85]. The
COPM has been used widely in intervention studies [85-
88] and previously demonstrated responsiveness to
change in studies evaluating BoNT-A and occupational
therapy in children with cerebral palsy [23,24,61,72].
Due to the age of the children in this RCT, parental
responses to the COPM were obtained rather than the
child's. This adaptation has been supported in findings by
Cusick et al. [89] who demonstrated acceptable internal
consistency reliability for performance (mean alpha =
0.73) and satisfaction (mean alpha = 0.82), content and
construct validity and responsiveness using this
approach. The five most important occupational perfor-
mance problem areas were selected using a 10-point
scale, where 1 equals "not important at all" and 10 equals
"extremely important". Performance in these areas was
then rated by a parent on two scales: perception of their
child's current performance and satisfaction with their
child's performance. Ratings were again on a 10-point
scale where scores closer to 10 indicated perceived better
performances and increased satisfaction. At baseline, a
total performance score was generated by summing the
performance scores and dividing by the number of identi-
fied problems. Similarly, a total satisfaction score was
generated by summing the satisfaction scores and divid-
ing by the number of problems. These scores range from
1 to 10 [81]. Upon re-assessment, performance and satis-
faction for each identified problem were again evaluated,
scored from 1 to 10. Change in performance and change
in satisfaction were calculated by subtracting Time 1 val-Hoare et al. BMC Neurology 2010, 10:58
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ues from Time 2, 3 or 4 values. There is evidence that a
change in summary scores (i.e. between initial and subse-
quent scores) of two or more is clinically significant [85].
The Goal Attainment Scale (GAS) is an individualized,
criterion-referenced measure of treatment-induced
change [90]. The GAS aims to measure an individual's
success in achieving functional goals that have been
determined prior to a treatment intervention. For this
RCT, the three most important areas of occupational per-
formance identified by parents using the COPM were
used as the three nominated goals for scaling the GAS.
During the baseline assessment session each goal was
rated on a 5-point scale from -2 (current level of perfor-
mance), -1 (less than expected outcome), 0 (expected out-
come), +1 (more than expected outcome) to +2 (much
greater than expected outcome). In the assessment peri-
ods during and after treatment (i.e. 1, 3 & 6 months post
BoNT-A) parents were again asked by the blinded asses-
sor to rate their child's performance in the three identi-
fied goals using the 5-point scale. Goals were not
weighted and were therefore assessed as being of equal
importance.
Using mathematical formulae, Kiresuk et al. [90] pro-
vide a method for summing the goals and converting
them to a T-score. A T-score of 50 indicates that the goals
were, on average, achieved [90]. Despite violating mathe-
matical principles, most intervention trials using the GAS
have adopted this methodology for analysis of GAS data.
The T-score calculation implies data obtained from GAS
are interval level and uni-dimensional in nature. This
however, may not be the case and using these calculations
when the assumptions are violated has been found to
compromise the interpretation of change scores and con-
found the interpretation of parametric statistical tests
[91]. In this RCT, the proportion of achieved goals was
analysed. Achieved goals, that is those that change from -
2 (baseline level of performance) to 0 (expected level of
performance) will represent a clinically significant
change.
The GAS has been used in five out of ten RCT's evalu-
ating the use of BoNT-A and occupational therapy in
children with cerebral palsy making it the most com-
monly used outcome measure across these trials. Despite
its popularity and reported sensitivity to detect change,
the validity and reliability of GAS is largely unknown [92].
Validity has been questioned, due to dependence on the
skill of the therapists who scale the goals, their objectivity,
and ability to select realistic goals and anticipate out-
comes following a specific intervention [93]. With regard
to sensitivity to change, Steenbeek et al. [92] reports that
the responsiveness of GAS "depends on whether thera-
pists and parents select goals and levels of attainment for
each goal that represent clinically important changes in
future performance" [[92], p. 553]. In this RCT, a single
blinded assessor developed goals for each child and each
goal was re-rated at each time point with the same par-
ent.
The Pediatric Motor Activity Log [94] Version 1, is a
parental rating on the frequency of use and quality of
movement of the affected upper limb in 22 tasks.
Despite its use in studies evaluating CIMT [35,94], and
a decision in 2003 to include the original version of the
PMAL in this RCT, the measure has since been found to
have inadequate construct validity and reliability [95].
Recent Rasch measurement modeling undertaken by
Wallen and colleagues [95] found that the original scales
of the PMAL had disordered rating structure. A revised
version of the scale has been recommended which dem-
onstrates strong test-retest reliability and adequate sensi-
tivity to change. The new, collapsed scale however, may
not adequately detect change in children at the extremes
of ability and requires further exploration before it can be
used as an outcome measure [95]. Unfortunately discus-
sions with Wallen [95] indicated that transformation of
the data from the original PMAL version obtained in this
RCT into the revised PMAL would not be valid. This is
because significant rewording of items and scoring crite-
ria between versions has been required to validate the
new tool. Based on Wallen and colleagues [95] findings of
inadequate psychometrics of the version used in this
RCT, PMAL outcomes will not be analysed or reported.
Intervention
Botulinum toxin-A
Each child in the study received injections of BoNT-A
(Allergan Australia P/L, Gordon, NSW, Australia) by a
single, highly experienced rehabilitation specialist (HBR).
Muscles injected were determined by the rehabilitation
specialist in consultation with the chief investigator (BJH)
a t  t h e  P h y s i c a l  R e h a b i l i t a t i o n  c l i n i c  b a s e d  o n  w h e t h e r
they appear to contribute to abnormal limb position and
impair functional use of the limb. Injected muscles
included  biceps brachii, brachialis, brachioradialis,
pronator teres, pronator quadratus, flexor carpi ulnaris,
flexor carpi radialis, flexor digitorum profundus, flexor
digitorum superficialis, flexor pollicis longus, adductor
pollicis, and opponens pollicis. If indicated, children also
received injections of BoNT-A into lower limb muscles
during the same injection session. This was considered
ethically appropriate for the child's overall management
and was considered unlikely to interfere with upper limb
outcomes. Injections were performed in theatre under a
light general anaesthetic and all children were discharged
on the same day. Muscle localisation was undertaken by
the use of Teflon coated Botox injection needles (37 mm,
27 gauge) allowing electrical stimulation. Doses of BoNT-
A were administered at a maximum dose of 15 U/kg (or
400 U). Dilution was 100 U/1 ml. During the first monthHoare et al. BMC Neurology 2010, 10:58
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following injection, the chief investigator (BJH) reviewed
all children on two occasions to monitor the effect of the
BoNT-A, identify potential adverse events and provide
splinting intervention as required.
Splinting
Children with increased resistance to passive stretch or
who exhibit early signs of muscle shortening were pro-
vided with a thermoplastic stretching splint designed for
use overnight for a minimum of 6 hours per night. This
protocol has been based on scientific support from a
small number of animal studies reporting that muscles
i n c r e a s e  i n  l e n g t h  w h e n  i m m o b i l i s e d  i n  a  l e n g t h e n e d
position [96,97] and a few studies in adult lower limb lit-
erature that suggest a prolonged low load stretch is more
effective than brief stretches in preventing contracture
[98,99]. For children with cerebral palsy, evidence that
static splinting maintains the mechanical-elastic proper-
ties of muscle remains weak [100]. Because passively
positioning a joint during active movement and covering
the skin is considered to limit the potential to strengthen
antagonist muscles and impede sensory feedback from
the hand, no day splints (i.e. neoprene, Second Skin(r),
thermoplastic wrist cock-up) were used during enrol-
ment in the RCT.
Movement-based therapy: General Considerations
One-month following injection of BoNT-A, children ran-
domised to the experimental group received modified
constraint-induced movement therapy (mCIMT). Chil-
dren randomised to the control group received conven-
tional bimanual occupational therapy (BOT). The
individual-based treatment sessions of 45 to 60 minutes
were conducted by the same occupational therapist (BJH)
twice weekly for 8 weeks in an outpatient paediatric treat-
ment room. In addition, children in the mCIMT experi-
mental group were required to complete 3 hours of home
program (with the mitt on), 7 days a week for the 8 week
treatment period. Children in the BOT control group
were also encouraged to undertake a home program but
no time requirements were specified. A checklist was
completed after each treatment session, identifying the
activities used and general observations. Important gen-
eral considerations for both groups related to establishing
and maintaining rapport, equipment, preparing and
implementing the sessions are described below.
Building rapport and establishing the therapist-child/
therapist-parent relationship was a primary focus for ini-
tial treatment sessions. Along with identifying individual
movement, hand skill and motor planning abilities of
each child, this time allowed for selection of toys to
match the demands of the task with the child's develop-
mental level and specific hand skill goals. It was also nec-
essary to establish expectations for future sessions, create
an understanding of acceptable behaviour and to estab-
lish patterns of on-task behaviour for the child.
Most treatment was undertaken with the child sitting at
a height adjustable table (See Figure 1). The therapist sat
on a wheeled chair usually positioned on the child's
affected side or behind the child. The child's chair, with
footrest, armrest and pommel was adjusted so that the
table was at waist height. This prevented the child from
leaving the table to wander around the room or slip under
the table. The therapist and child's position also: allowed
the treatment to focus on hand skill development; pro-
vided adequate freedom of movement of upper limbs for
reach and grasp; allowed visual monitoring of the hands
during tasks; assisted in maintaining attention on the
task; provided control of the child's immediate environ-
ment and; appropriately positioned the therapist to pro-
vide modelling of tasks and verbal and physical assistance
with an emphasis on the required hand placement and
movements, the task sequence and general demands of
Figure 1 Table and chair used in therapy sessionsHoare et al. BMC Neurology 2010, 10:58
http://www.biomedcentral.com/1471-2377/10/58
Page 11 of 20
the task. Parents were seated opposite the child or on the
child's unaffected side and beyond the child's reach.
Prior to each session a carefully selected range of fun
and motivating toys were placed in the treatment room
on an uncovered bench behind or to the side of the child's
chair. To improve motivation the child was actively
encouraged to choose the toys with which they wished to
play. Periods without the child actively engaged in play
were avoided to maintain motivation, attention and con-
centration. If the child became distracted, techniques
such as using noise and sensory input (e.g. tapping the
table with a toy, tapping the child's affected hand, raising
volume of voice) were used to redirect their attention to
the task. Because task repetition and practice are key
components of training, any attempt by the child to pre-
maturely stop task performance (i.e. by focussing on
something else in the room) was ignored by the therapist
and parent and the child's attention redirected to the task.
The child was required to indicate when an activity had
been finished through verbalisation or physical signs. If
this occurred after only a few repetitions, further repeti-
tions were negotiated before the activity is stopped. This
was seen as important for compliance and motivation as
the child felt included in the decision making process
whilst further task repetition was achieved. No new activ-
ities were chosen until all parts of the activity had been
packed up. This was crucial as repetitions of movement/
hand skills achieved through packing up were often
greater than in the activity itself.
With novel and/or challenging tasks, an inability to
independently and successfully complete the demands of
the task often leads to a child becoming disinterested or
frustrated after only a few trials or repetitions. To facili-
tate learning, improve skills and task performance,
develop resilience, and for the therapist to assist the child
to establish patterns of on-task behaviour it was impor-
tant not to allow the child to "give up" or avoid tasks. A
variety of task-avoidant behaviours can be successfully
used by children from a very early age. Initial and ongoing
parent/therapist reinforcement can inadvertently condi-
tion task-avoidant behaviour, impeding the participation
and engagement of the child and therefore the effective-
ness of treatment. It was crucial for the therapist to estab-
lish a collaborative partnership with the parents to ensure
consistent responses to these behaviours. On occasions
where task avoidant behaviours became evident, the ther-
apist provided advice and strategies to the parent(s) on
appropriate responses to avoid reinforcement. Examples
of typical task-avoidant behaviours displayed by children
included:
• Throwing objects - this often occurs when a child
does not understand the requirement of the task (poor
motor planning) or the task is too challenging for the
child's abilities. In this RCT the therapist always modelled
novel task performance to demonstrate task demands.
During early attempts at a task, significant physical assis-
tance and/or verbal cuing were provided to ensure suc-
cessful performance. The amount of assistance was then
gradually decreased with future attempts. Any object
thrown by the child was not collected by the therapist/
parent and the behaviour was ignored. The object
remained on the floor to ensure the child did not receive
a response that reinforced the behaviour (i.e. stopping of
activity, collection by parent). If the behaviour persisted
the therapist pre-empted the throw preventing it from
happening. The child's attention was redirected to the
task and, if required, additional modelling of task perfor-
mance or increased physical assistance was provided.
• Mouthing objects - young children can learn that
mouthing objects leads to a quick and alarmed reaction
from the parent/therapist that leads to diversion of atten-
tion away from the task. During treatment if a child dem-
onstrated this behaviour, objects small enough for
ingestion were avoided in all sessions until the behaviour
ceased. To avoid encouraging this behaviour, larger
objects were used (to ensure ingestion was not possible)
and the behaviour was ignored when displayed. Any
direct eye contact with the child from the parent and
therapist was also avoided and directed to the task, so the
child did not receive a response (i.e. facial expression
from parent/therapist, verbal feedback).
• Crying can be an extremely effective strategy for task-
avoidance by young children. The reinforcement of this
behaviour occurs when the therapist immediately stops
the task or parents intervene to provide comfort and
reassurance through physical contact or removal of the
child from the activity. The child can associate crying
with successful task avoidance with resultant disruption
to the session. During treatment, it was important for the
therapist to quickly evaluate the situation. If the child was
obviously distressed, parental comfort and reassurance
was used to settle the child. Removal from the seat was
avoided if at all possible. If the child was not obviously
distressed and crying was deemed by the therapist/parent
as task-avoidant behaviour the task was continued. A
graded level of response was initiated: 1) child was not
removed from position; 2) therapist negotiated with the
child for one or two more repetitions prior to task com-
pletion; 3) therapist verbalised when task was completed
4) child was required to pack up the activity before
choosing next activity; 5) if the child remained uncooper-
ative the therapist and parent engaged in conversation or
played the task/game whilst ignoring the child's behav-
iour; 6) if the child remained uncooperative the therapist
asked the child if they would like the parent to leave the
room; 7) as a last resort, if the child remained uncoopera-
tive the parent left the room until the child settled. As
soon as the child settled the parent was invited back intoHoare et al. BMC Neurology 2010, 10:58
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the room. Great care was taken with this final response as
it had the potential to cause significant anxiety and stress
to the child. Over time, with consistent responses to cry-
ing from the parent and therapist, it was expected that
the child would stop using crying as a technique for task
avoidance.
Constraint-induced movement therapy
The modified constraint-induced movement therapy
(mCIMT) protocol incorporated the two fundamental
components of CIMT as described by Taub et al. [36]: the
use of a restraint device (glove) and; the provision of
massed practice to the affected upper limb (3 hours of
home program). A comfortable neoprene (wet suit mate-
rial) glove was worn on the hand of the non-affected
upper limb to facilitate intensive practice of the affected
upper limb. The neoprene glove, with a palmar thermo-
plastic insert over the fingers and thumb to prevent grasp,
allowed the child to use the hand as an effective assist in
bilateral activities, but did not allow active grasp of
objects (see Figure 2). Importantly, the glove allowed the
child to use the unaffected limb for breaking a fall, if
needed. The intervention period was 2 months and
involved wearing the glove 7 days per week. Children
were expected to wear the glove for 3 hours per day,
including therapy time and the home program, which
could be split into different sessions of no less than 30
minutes duration. Families were expected to undertake
an intensive home program of 3 hours per day. This could
occur in the child's usual environment including home,
crèche, preschool or school. Caregivers completed a log-
book detailing the total period the restraint device was
worn per day and any issues arising from use of the glove.
The intention of the home program was to facilitate an
intensive period of practice with the affected limb and to
educate, empower and include families and caregivers in
the treatment process. Families were provided with writ-
ten and specific goals by the treating therapist after each
session. These were based around development of spe-
cific hand skills such as grasp, hold, release, reach, in-
hand manipulation. Families were encouraged to focus on
these goals during the home program. Families were dis-
couraged from placing the glove on the child without
supervision to avoid frustration.
The implementation of mCIMT was based on the prin-
ciples of motor-learning theory [30,101]. Eliasson [30]
comprehensively describes the core principles of motor-
learning including "learning to perform a task by develop-
ing strategies, learning a task by practicing skills and
learning to use the hemiplegic hand through task practic-
ing" (p. 56). Consideration of these principles highlights
the important differences between adopting a motor
learning approach within a CIMT protocol compared
with a BOT protocol. Although both approaches use sim-
ilar principles for development of motor skills (i.e. moti-
vation and learning through repetitive practice), the uni-
manual nature of CIMT only allows for practice of gen-
eral aspects of hand function rather than the activity itself
[30]. For the mCIMT group in this RCT, the uni-manual
treatment focussed on repetitive practice of movements
and skills with the affected limb (e.g. grasp, release, hold-
ing and transporting of balls into a ball tower, holding
paint stamps and using adapted brushes, stacking blocks
and other objects, holding a magnetic wands to catch a
ball, magnetic fishing games, hammering games, Jenga).
Using constraint of the unaffected upper limb and utilis-
ing games and play, uni-manual tasks were carefully
selected to provide sufficient challenge and successful
outcomes when using the affected upper limb. In doing
so, learning was facilitated by practicing skills and the
experience of using the hand through massed practice. It
was not possible to target learning of bimanual strategies
to achieve task performance.
Activities deemed too difficult by the therapist were
avoided to prevent experiences of failure and frustration.
This was particularly important in initial sessions where
simple cause and effect activities were used (e.g. battery
operated switch activated toys). Parents were educated
Figure 2 Neoprene glove used in modified constraint-induced 
movement therapy.Hoare et al. BMC Neurology 2010, 10:58
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that use of the glove must be perceived by the child as fun
and enjoyable. Rewards, such as playing with favourite
toys when the glove was used, was highly encouraged.
Negative experiences, such as verbal threats and with-
drawal of activities, were discouraged. The child was
always kept busy and periods without the child actively
engaging in play was avoided. If the child became dis-
tracted by the glove their attention was immediately redi-
rected to the task by using noise and sensory input (e.g.
tapping the table with a toy, tapping the child's affected
hand, raising volume of voice). Any discussion regarding
the glove was avoided. At the conclusion of each session
the child was praised and informed the session had fin-
ished and the child was encouraged to independently
remove the glove using his or her affected hand.
Bimanual Occupational Therapy
The bimanual occupational therapy (BOT) was under-
pinned by components of motor learning [102] and cog-
nitive-based motor intervention [103,104]. This eclectic
approach to treatment is commonly adopted by occupa-
tional therapists in the training of upper limb motor skills
in children with cerebral palsy [30]. Details of the compo-
nents adopted from motor skill acquisition, motor learn-
ing and motor control theory, the Assisting Hand
Assessment hierarchy and cognitive based approaches
are described below.
Motor skill acquisition, motor learning and motor 
control theory Practical application of a motor learning
framework requires implementation of a motor-teaching
model whereby the therapist acts as a teacher and the
child, a learner. Factors required to facilitate a child's
learning of motor skills include: giving attention to the
context; motivation and prior knowledge; instructions;
modelling; taxonomy and sequencing of tasks; anticipa-
tion skills; mental and physical practice; repetition; facili-
tation-guidance; and feedback [102]. Similar core
components have been outlined for improving motor
skills in children using a motor skills acquisition frame of
reference [27]. These frameworks [27,102], along with
more recent advances in the knowledge of motor plan-
ning difficulties experienced by children with cerebral
palsy [30,105], formed the core components of the BOT
provided in this RCT. Examples of the practical imple-
mentation of these principles included:
• Initial and ongoing task analysis to identify if the
child's performance was limited by execution of move-
ment or motor planning difficulties (i.e. sequencing of
movements) [30,105,106]. Motor planning impairment
was observed by presenting a child with a novel task
without prior modelling or task demonstration. It is evi-
dent when you know the child has the underlying physi-
cal capacity to complete the task but they simply cannot
organise or plan the sequence of actions or required
movements of the hands to successfully perform the task.
• Repetitive whole-task practice of challenging, moti-
vating and purposeful bimanual activities (i.e. toys and
games), carefully selected to facilitate learning and devel-
opment of goal-based skills and independence with task
completion [101].
• Use of modelling, physical assistance, verbal cues or
environmental adaptation to enable the child to under-
stand the critical features of the task and the environ-
ment.
• Facilitation of the child's learning and understand-
ing of the role of their assisting hand (i.e. hemiplegic 
hand) using active problem solving.
• Grading of physical and/or verbal assistance provided
to complete tasks.
• Provision of feedback focusing on the outcome, task
and environment rather than specific movement perfor-
mance.
• Provision of opportunities for the child to repetitively
practice tasks in a range of contexts and environments.
Understanding and grading task difficulty in 
bimanual intervention The Assisting Hand Assessment
(AHA), designed specifically for children with unilateral
impairment, was developed using a Rasch measurement
model. This model allowed identification and ordering of
the AHA test items on a scale from easiest to hardest. For
example, simply approaching an item using the affected
hand (easier item) to using in-hand manipulation skills to
move objects in the affected hand (more difficult item).
Based on the Rasch model, easier items are more likely to
be easier to perform for all children than more difficult
items. More able children are also more likely to perform
better on more difficult items than less able children. The
unique construct allows children's bimanual upper limb
ability levels to be placed along a continuum of low ability
t o  h i g h  a b i l i t y .  T h i s  k n o w l e d g e  c a n  b e  u s e d  t o  d e s i g n
intervention and guide graded task performance [107].
For example, attempting to improve the bimanual perfor-
mance of a child with low ability to place objects directly
onto a table (most difficult item) using the assisting hand
is inappropriate. Treatment for this child should focus on
the development and consolidation of easier items such
as holding objects or stabilising by grip. Conversely, con-
tinually focussing on easier items for a child with high
abilities will not serve to improve their abilities on more
difficult items. In this RCT, although specific details of
the AHA scores remained unknown to the treating thera-
pist, knowledge of the AHA hierarchy served as an
important guide for selecting specific activities during the
implementation of BOT. Treatment was tailored to the
individual child based on their typical performance in the
initial treatment sessions (see Figure 3).
Cognitive approach Children with hemiplegic cerebral
palsy have varied abilities to perform bimanual activities.
Often children have the underlying motor abilities (i.e.Hoare et al. BMC Neurology 2010, 10:58
http://www.biomedcentral.com/1471-2377/10/58
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adequate range of movement, ability to grasp, hold and
release) to execute the required movements for task per-
formance, however they are unable to independently
identify the specific role for each hand, appropriately
position the hands and object or sequence the move-
ments or direction of force required to complete the task.
These motor planning difficulties may be just as limiting
for the performance of activities of daily living as is move-
ment execution in children with cerebral palsy [105].
Cognitive-based approaches [103,104] have evolved
and been adapted for use in approaches such as Cognitive
Orientation to daily Occupational Performance (CO-OP).
Developed in the 1990's for the treatment of motor disor-
ders in children with DCD [88,108], CO-OP is a task ori-
ented problem-solving approach that utilises cognitive
skills to improve occupational performance [109]. The
child is guided to develop his/her own strategies based on
problems encountered during a task. In this RCT, the
bimanual approach to training was grounded in cogni-
tive-based intervention theory. Much of the treatment
targeted the motor planning abilities of children with
both low and high bimanual abilities. Children engaged in
a self-instructional training program that was carefully
facilitated by the treating therapist [110]. In the context of
this RCT, the treating therapist reinforced to children
that the difficulties they often experienced with task per-
formance was because they were not taking advantage of
certain strategies or tricks that they could learn [110].
Novel activities were chosen which the child could only
solve by carefully looking and listening, and for which a
plan or strategy was required before any movement or
action took place (e.g. pushing plastic links together).
Attempts were made to encourage the child to plan ahead
and reduce impulsive tendencies to quickly grab the
object using their dominant hand before they thought
about the role of affected hand in the task. Before hand-
ing the toy to the child, the therapist demonstrated
exactly what was involved to complete the task. The ther-
apist modelled the required movements and emphasised
important sequences and strategies whilst verbalising
these aloud using simple, key words. Deliberately, the
therapist occasionally performed components of the task
incorrectly and talked through how they could be cor-
rected. The child was then handed the activity and
encouraged to slowly perform the task using the
sequences modelled by the therapist whilst using the
Figure 3 Using the Assisting Hand Assessment hierarchy to grade treatment. DH = Dominant Hand; AH = Assisting HandHoare et al. BMC Neurology 2010, 10:58
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same verbalisations, or verbalisations the child had devel-
oped. These verbalisations during task performance have
been referred to as verbal mediation. The mediators serve
to teach the child how to comprehend a task, direct
motor movement through self commands and impor-
tantly, to guide, monitor and control their own perfor-
mance [111]. If the child had difficulty performing a
previously practiced task, the therapist prompted the
child using recall of verbal mediators (see Figures 4 and
5). Importantly, this technique was demonstrated and
reinforced to parents to ensure a similar process is under-
taken in the home environment.
Identifying and breaking down the specific sequences
of a task allowed the therapist to assist the child to dis-
cover deficient sequences and to prompt them to con-
sider the error before the end of the whole task. This
inhibits failure of the task at an incipient stage thereby
reducing the likelihood that the child will become frus-
trated or non-compliant [111]. Typically, children
become more motivated if they have been active and suc-
cessful participants in the problem solving process. Over
time, this approach aims to promote a child's resilience by
independently prompting themselves to identify incor-
rect sequences before becoming angry or frustrated.
With proficiency in performance the need for self-
rehearsal diminishes [111]. Importantly, the child learns
how to learn. In an attempt to facilitate generalisation of
the learning, task practice in this RCT was encouraged in
various environments (i.e. using home programs) and
with different activities that required similar strategies
[110].
Statistical analysis
Data were managed and analysed using the Statistical
Package for Social Sciences (SPSS version 16.0). Descrip-
tive statistics were calculated to summarise the data set
for both groups and to identify potential baseline differ-
ences between the groups; p values were used to indicate
the strength of the evidence and will be interpreted
according to Sterne and Davey Smith [112] Distributions
of data from each group and for each occasion were
assessed to determine if they met the assumptions for the
various inferential analyses.
Testing the effectiveness of therapy (Hypotheses 1 and 2)
Using continuous, interval level data from the AHA, dif-
ferences between the two groups were assessed using a
linear regression approach to analysis of covariance
(ANCOVA). This controlled for the covariates of baseline
AHA scores and the child's age. These variables were
Figure 4 Development of grasp, hold and release using verbal mediatorsHoare et al. BMC Neurology 2010, 10:58
http://www.biomedcentral.com/1471-2377/10/58
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included as covariates as they might provide alternative
explanations for any observed changes in scores. The size
of treatment effect was estimated by comparing differ-
ences in group means and their 95% confidence intervals.
Regression analyses and scatter-plots were used to inves-
tigate the relationship of post-treatment outcome with
initial deficit.
Testing the effect of therapy on secondary outcomes 
(Hypothesis 3)
Between group differences were assessed using ANOVA
for continuous data (following tests of normality). Out-
comes that had non-continuous data or did not meet
usual assumptions of linear regression were investigated
using non-parametric statistics.
Testing the clinical significance of the effect of therapy on 
primary outcome (Hypothesis 4)
The magnitude of treatment effect was evaluated relative
to defined criterion of clinical significance.
Testing the effect of age and intensity of therapy (Hypotheses 
5 & 6)
Data related to the number of minutes spent by all chil-
dren undergoing treatment was extracted from the log
book for each child. Associations between the intensity of
therapy and outcome and age of children and outcome
were determined, while controlling for the covariate of
group, using ANCOVA.
Safety evaluation
Each child was monitored throughout the trial period by
the chief investigator. Following trial completion, all med-
ical and research records were retrospectively audited.
Any adverse events were recorded and classified accord-
ing to whether they could be attributed to BoNT-A injec-
tion, general anaesthesia or movement-based treatment.
Current study status
The study commenced recruitment in May 2003 and
achieved target recruitment in September 2008. Partici-
pant follow-up was completed in March 2009. Data anal-
ysis is currently being undertaken.
Amendments to the study since commencement (2003)
(1) Extension for completion date
Approval was granted by Southern Health and La Trobe
University Ethics Committees to extend the completion
date of the project to June 2010. Approval was requested
due to the trial being behind schedule due to slow
recruitment rates.
Figure 5 Development of stability of grip using a cognitive-motor approach to treatment.Hoare et al. BMC Neurology 2010, 10:58
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(2) Inclusion criteria
In March 2005 approval was granted by Southern Health
and La Trobe University Ethics Committees to extend the
upper age limit of children included in the trial from 4 to
6 years of age. Modification was requested due to the
development of the upper age limit for the AHA, allowing
the effective/valid measurement of children aged 4 to 6
years old. Children in this age range were also considered
to potentially benefit from the treatments provided in the
trial and therefore would be a clinical population these
treatments would be offered to in the future.
Discussion
This paper describes the methodology of a randomised
controlled trial comparing the effects of modified con-
straint-induced movement therapy (a uni-manual ther-
apy) versus conventional occupational therapy (a
bimanual therapy) on improving bimanual upper limb
performance of young children with hemiplegic cerebral
palsy following upper limb injection of BoNT-A. The
results of the paper will be disseminated through peer
reviewed journal publications.
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